J. R. Riordan, The cystic fibrosis transmembrane conductance regulator, Annu. Rev. Physiol, vol.55, pp.609-630, 1993.

J. R. Riordan, Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA, Science, vol.245, pp.1066-1073, 1989.

S. M. Rowe, S. Miller, E. J. Sorscher, and . Cystic-fibrosis, N. Engl. J. Med, vol.352, 1992.

P. R. Sosnay, Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene, Nat. Genet, vol.45, pp.1160-1167, 2013.

S. H. Cheng, Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis, Cell, vol.63, pp.827-834, 1990.

G. M. Denning, L. S. Ostedgaard, and M. J. Welsh, Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia, J. Cell Biol, vol.118, pp.551-559, 1992.

N. Kartner, O. Augustinas, T. J. Jensen, A. L. Naismith, and J. R. Riordan, Mislocalization of ?F508 CFTR in cystic fibrosis sweat gland, Nat. Genet, vol.1, pp.321-327, 1992.

P. J. Thomas, P. Shenbagamurthi, J. Sondek, J. M. Hullihen, and P. L. Pedersen, The cystic fibrosis transmembrane conductance regulator. Effects of the most common cystic fibrosis-causing mutation on the secondary structure and stability of a synthetic peptide, J. Biol. Chem, vol.267, pp.5727-5730, 1992.

W. Dalemans, Altered chloride ion channel kinetics associated with the ?F508 cystic fibrosis mutation, Nature, vol.354, pp.526-528, 1991.

G. L. Lukacs, The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells, J. Biol. Chem, vol.268, pp.21592-21598, 1993.

M. Gentzsch, Endocytic trafficking routes of wild type and ?F508 cystic fibrosis transmembrane conductance regulator, Mol. Biol. Cell, vol.15, pp.2684-2696, 2004.

M. Sharma, Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes, J. Cell Biol, vol.164, pp.923-933, 2004.

T. Okiyoneda, Peripheral protein quality control removes unfolded CFTR from the plasma membrane, Science, vol.329, pp.805-810, 2010.

F. Van-goor, Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770, Proc. Natl. Acad. Sci, vol.106, pp.18825-18830, 2009.

F. Van-goor, Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809, Proc. Natl. Acad. Sci, vol.108, pp.18843-18848, 2011.

C. E. Wainwright, Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del, N. Engl. J. Med, vol.373, pp.220-231, 2015.

G. M. Denning, Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive, Nature, vol.358, pp.761-764, 1992.

W. M. Rabeh, Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore ?F508 CFTR Folding and Function, Cell, vol.148, pp.150-163, 2012.

T. Heged?s, F508del CFTR with two altered RXR motifs escapes from ER quality control but its channel activity is thermally sensitive, Biochim. Biophys. Acta BBA -Biomembr, vol.1758, pp.565-572, 2006.

W. Wang, G. O. Okeyo, B. Tao, J. S. Hong, and K. L. Kirk, Thermally Unstable Gating of the Most Common Cystic Fibrosis Mutant Channel (?F508): "Rescue" by Suppressor Mutations in Nucleotide Binding Domain 1 and by Constitutive Mutations in the Cytosolic Loops, J. Biol. Chem, vol.286, pp.41937-41948, 2011.

Y. Wang, Z. Cai, M. Gosling, and D. N. Sheppard, Potentiation of the cystic fibrosis transmembrane conductance regulator Cl ? channel by ivacaftor is temperature independent, Am. J. Physiol.-Lung Cell. Mol. Physiol, vol.315, pp.846-857, 2018.

M. Sharma, M. Benharouga, W. Hu, and G. L. Lukacs, Conformational and Temperature-sensitive Stability Defects of the ?F508 Cystic Fibrosis Transmembrane Conductance Regulator in Post-endoplasmic Reticulum Compartments, J. Biol. Chem, vol.276, pp.8942-8950, 2001.

A. Jurkuvenaite, Functional Stability of Rescued ?F508 Cystic Fibrosis Transmembrane Conductance Regulator in Airway Epithelial Cells, Am. J. Respir. Cell Mol. Biol, vol.42, pp.363-372, 2010.

X. Liu, N. O'donnell, A. Landstrom, W. R. Skach, and D. C. Dawson, Thermal Instability of ?F508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channel Function: Protection by Single Suppressor Mutations and Inhibiting Channel Activity, Biochemistry, vol.51, pp.5113-5124, 2012.

C. Boinot, M. Souchet, R. Ferru-clement, and F. Becq, Searching for Combinations of Small-Molecule Correctors to Restore F508del-Cystic Fibrosis Transmembrane Conductance Regulator Function and Processing, J. Pharmacol. Exp. Ther, vol.350, pp.624-634, 2014.

A. Billet, L. Froux, J. W. Hanrahan, and F. Becq, Development of Automated Patch Clamp Technique to Investigate CFTR Chloride Channel Function, Front. Pharmacol, vol.8, 2017.

X. Meng, Two Small Molecules Restore Stability to a Subpopulation of the Cystic Fibrosis Transmembrane Conductance Regulator with the Predominant Disease-causing Mutation, J. Biol. Chem, vol.292, pp.3706-3719, 2017.

T. Ma, Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion, J. Clin. Invest, vol.110, pp.1651-1658, 2002.

G. Veit, Some gating potentiators, including VX-770, diminish F508-CFTR functional expression, Sci. Transl. Med, vol.6, pp.246-97, 2014.

D. M. Cholon, Potentiator ivacaftor abrogates pharmacological correction of F508 CFTR in cystic fibrosis, Sci. Transl. Med, vol.6, pp.246-96, 2014.

D. M. Cholon, C. R. Esther, and M. Gentzsch, Efficacy of lumacaftor-ivacaftor for the treatment of cystic fibrosis patients homozygous for the F508del-CFTR mutation, Expert Rev. Precis. Med. Drug Dev, vol.1, pp.235-243, 2016.

J. C. Davies, VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles, N. Engl. J. Med, vol.379, pp.1599-1611, 2018.

D. Keating, VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles, N. Engl. J. Med, vol.379, pp.1612-1620, 2018.

J. M. Collaco, Effect of Temperature on Cystic Fibrosis Lung Disease and Infections: A Replicated Cohort Study, PLoS ONE, vol.6, p.27784, 2011.

J. M. Collaco, L. J. Appel, J. Mcgready, and G. R. Cutting, The relationship of lung function with ambient temperature, PLOS ONE, vol.13, p.191409, 2018.

C. Wang, Ligand binding to a remote site thermodynamically corrects the F508del mutation in the human cystic fibrosis transmembrane conductance regulator, J. Biol. Chem. jbc.RA117, vol.000819, 2018.

M. P. Anderson and M. J. Welsh, Calcium and cAMP activate different chloride channels in the apical membrane of normal and cystic fibrosis epithelia, Proc. Natl. Acad. Sci, vol.88, pp.6003-6007, 1991.

E. M. Schwiebert, T. Flotte, G. R. Cutting, and W. B. Guggino, Both CFTR and outwardly rectifying chloride channels contribute to cAMP-stimulated whole cell chloride currents, Am. J. Physiol.-Cell Physiol, vol.266, pp.1464-1477, 1994.

P. Linsdell and J. W. Hanrahan, Disulphonic stilbene block of cystic fibrosis transmembrane conductance regulator Cl-channels expressed in a mammalian cell line and its regulation by a critical pore residue, J. Physiol, vol.496, pp.687-693, 1996.

A. Tousson, B. A. Van-tine, A. P. Naren, G. M. Shaw, and L. M. Schwiebert, Characterization of CFTR expression and chloride channel activity in human endothelia, Am. J. Physiol.-Cell Physiol, vol.275, pp.1555-1564, 1998.